ID: ALA473929

Max Phase: Preclinical

Molecular Formula: C12H16N4O3S

Molecular Weight: 296.35

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 5'-Methylthio-Immh
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CSC[C@H]1N[C@@H](c2c[nH]c3c(=O)[nH]cnc23)[C@H](O)[C@@H]1O

    Standard InChI:  InChI=1S/C12H16N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6,8,10-11,13,16-18H,3H2,1H3,(H,14,15,19)/t6-,8+,10-,11+/m1/s1

    Standard InChI Key:  CEGIKIXYDFDYDN-RXDXJJGDSA-N

    Associated Targets(Human)

    Purine nucleoside phosphorylase 774 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    S-methyl-5'-thioinosine phosphorylase 16 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Purine nucleoside phosphorylase 3 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium falciparum 966862 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 296.35Molecular Weight (Monoisotopic): 296.0943AlogP: -0.65#Rotatable Bonds: 3
    Polar Surface Area: 114.03Molecular Species: NEUTRALHBA: 6HBD: 5
    #RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 10.03CX Basic pKa: 8.20CX LogP: -1.34CX LogD: -2.10
    Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.51Np Likeness Score: 0.47

    References

    1. Murkin AS, Clinch K, Mason JM, Tyler PC, Schramm VL..  (2008)  Immucillins in custom catalytic-site cavities.,  18  (22): [PMID:18778937] [10.1016/j.bmcl.2008.08.047]
    2.  (2016)  Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase, 
    3. Cheviet T, Lefebvre-Tournier I, Wein S, Peyrottes S..  (2019)  Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.,  62  (18): [PMID:30964283] [10.1021/acs.jmedchem.9b00182]